Close
Select up to 3 companies
| Company |
Synthetic Genomics
|
|
|
|
|---|---|---|---|---|
| Short Description | Developer of genomic-based solutions for different industries including energy, food, agriculture, water and medicine now renamed Viridos |
|
|
|
| Status | Other |
|
|
|
| Year Founded | 2005 |
|
|
|
| Industry Group |
|
|
|
|
| Sector |
|
|
|
|
| TRL Range | 4-6 |
|
|
|
| Country | United States |
|
|
|
| Nbr Employees | 101-250 |
|
|
|
| Revenue Range |
|
|
|
|
|
Total Equity Capital Raised |
$165M |
|
|
|
|
Last Stage Capital Raised |
Growth Equity
round of
$50M
2014 |
|
|
|
| Investors | BP Ventures, Biotechonomy, Threshold Ventures, Plenus (Mexico), Meteor Group, Monsanto Growth Ventures, Lung Biotechnology |
|
|
|
Investment Data Information
Investment data is not editable by profile owners.
Please contact research@cleantech.com to make changes.
Close
Hey there!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!
Startups
Use i3 to gain visibility with corporations and investors looking to invest and partner with external technology companies.
Contact us
Use i3 to access market intelligence on companies, investors, market activity and innovation trends.
Are you involved with a startup or SME looking for strategic partners, investors, or customers? Create your free profile!
Contact us to discuss the full power of i3:
Close
Request Received!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Get in touch
We don't have team members for this company yet!
-
- J. Venter
- Co-Founder, Chairman, CEO, Co-Chief Scientific Officer
-
0 team members on i3
Message J.
Work at this company?
Claim this profile
Traction
Similar companies
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Back to top